News tagged with cancer vaccine

Cuba releases world's first lung cancer vaccine

(Medical Xpress) -- As the most common and deadliest form of cancer, lung cancer kills 1.4 million people per year worldwide, according to the World Health Organization. While current treatments may improve the survival rate ...

Sep 08, 2011
popularity 4.6 / 5 (40) | comments 20 | with audio podcast weblog

Hitchhiking vaccines boost immunity

Many vaccines, including those for influenza, polio, and measles, consist of a killed or disabled version of a virus. However, for certain diseases, this type of vaccine is ineffective, or just too risky.

Feb 17, 2014
popularity 5 / 5 (5) | comments 0

Early evidence of HPV vaccine impact

(PhysOrg.com) -- In a new study published in Lancet, researchers from Australia report evidence that the vaccine designed to target the human papillomavirus, or HPV, has dramatically dropped the incidence of les ...

Jun 20, 2011
popularity 5 / 5 (5) | comments 0 | with audio podcast report

New vaccine attacks breast cancer in mice

Researchers from the University of Georgia and the Mayo Clinic in Arizona have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer ...

Dec 12, 2011
popularity 5 / 5 (10) | comments 2 | with audio podcast

Researchers generate immunity against tumor vessel protein

Sometimes a full-on assault isn't the best approach when dealing with a powerful enemy. A more effective approach, in the long run, may be to target the support system replenishing the supplies that keep your foe strong and ...

Apr 25, 2014
popularity 5 / 5 (5) | comments 0

Cancer vaccine

The term cancer vaccine refers to a vaccine that either prevents infections with cancer-causing viruses, treats existing cancer or prevents the development of cancer in certain high risk individuals.

Some cancers, such as cervical cancer and some liver cancers, are caused by viruses, and traditional vaccines against those viruses, such as HPV vaccine and Hepatitis B vaccine, will prevent those cancers.

Scientists have also been trying to develop vaccines against existing cancers. Some researchers believe that cancer cells routinely arise and are destroyed by the healthy immune system; cancer forms when the immune system fails to destroy them. One approach to cancer vaccination is to separate proteins from cancer cells and immunize cancer patients against those proteins, in the hope of stimulating an immune reaction that would kill the cancer cells. Therapeutic cancer vaccines are being developed for the treatment of breast, lung, colon, skin, kidney, prostate, and other cancers..

On April 14 2009 Dendreon Corporation announced that their Phase III clinical trial of Provenge, a cancer vaccine designed to treat prostate cancer, had succeeded in demonstrating an increase in survival. This is the first robust, statistically significant Phase III result for a cancer vaccine, although the data have yet to be scrutinized by the U.S. Food and Drug Administration or by European Union regulatory agencies. Dendreon is forecasting marketing approval by the FDA by 2010

If Provenge is approved by the FDA, Dendreon will have opened a new era in cancer care.[citation needed]

This text uses material from Wikipedia licensed under CC BY-SA